Nucleus RadioPharma appoints Kathy Spencer-Pike as CCO

Nucleus RadioPharma has appointed Kathy Spencer-Pike as its chief commercial officer.

Kathy Spencer-Pike.Kathy Spencer-Pike.Business Wire

Spencer-Pike will lead the company's growth following Nucleus' $56 million series A funding round in October. The company also recently appointed Geoff Johnson, MD, PhD, as its chief scientific officer, Kevin Haehl as chief development officer, and Mark Przekop as chief operating officer.

Spencer-Pike previously served as chief sales officer at McKesson and as vice president for commercial leadership at Novo Nordisk.

Page 1 of 461
Next Page